New Therapy against B Cell Lymphomas based on Antibodies that recognize B cell Receptors
Efficient treatment strategy based on antigen-armed antibodies (AgAbs). After AgAb treatment Epstein-Barr virus-transformed B cell lines and various Burkitt’s lymphoma cell lines were able to present antigens that efficiently induce T cell activation.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Facing the Storm: A Prepped Up Future Against Extreme Climatic and Weather Changes
From the persistent droughts of southern Africa and Central America in the early part of the year to the more recent devastating extreme rainfall in Spain and the deadly Hurricane…
Magnetic Effect: Groundbreaking Discovery for Low-Temperature Thermoelectric Cooling
Researchers at the Max Planck Institute for Chemical Physics of Solids, in collaboration with Chongqing University and the Max Planck Institute of Microstructure Physics, have achieved a breakthrough in topological…
Parallel Paths: Understanding Malaria Resistance in Chimpanzees and Humans
The closest relatives of humans adapt genetically to habitats and infections Survival of the Fittest: Genetic Adaptations Uncovered in Chimpanzees Görlitz, 10.01.2025. Chimpanzees have genetic adaptations that help them survive…